Back

Dobutamine stress echocardiography as a screening tool for coronary artery disease detection in patients with end-stage liver disease awaiting transplantation

4 December 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Stress Echocardiography Stress Echocardiography EACVI Premium Access EuroEcho 2019

About the speaker

Photo
Doctor Chris Kapelios

Attikon University Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Detection of symptom related coronary arteries in patients with coronary artery disease by 4D stress echo with adenosine triphosphate
Doctor D. Safonov (Taganrog, RU)
Abstract Slides
Presentation thumbnail
Exercise echocardiographic determinants of exercise tolerance in aortic stenosis
Doctor P. Fazendas (Almada, PT)
Abstract Slides
Presentation thumbnail
Regional peak systolic longitudinal strain during dipyridamole stress echocardiography in patients with normokinetic response determined by visual assessment
Professor K. Wierzbowska-Drabik (Lodz, PL)
Abstract Slides
Presentation thumbnail
Assessment of functional mitral regurgitation with leg lift and exercise echocardiography using the average pixel intensity method
Doctor V. Kamoen (Roeselare, BE)
Abstract
Presentation thumbnail
Delta mapse: an easy-to-use tool to evaluate coronary artery stenosis during dypiridamole pharmacological stress echocardiography.
Doctor L. Moderato (Piacenza, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Stress Echocardiography

The Event

Event poster

EuroEcho 2019

4 December - 7 December 2019
You may be interested in
thumbnail
Congress Presentation
The do’s and don’ts from the EACVI clinical consensus statement on stress echocardiography
thumbnail
Congress Presentation
Stress echocardiography best defines risk
thumbnail
Congress Presentation
Valvular heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources